Skip to content

Clinical trials

Coronary Stenosis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Stenosis Country / region: China Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20071
20103
20112
20121
20132
20161
20171
20181
20192
20203
20213
20222
20235
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status12
Recruiting6
Active, not recruiting2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices5
China National Center for Cardiovascular Diseases4
Peking Union Medical College Hospital3
CCRF Inc., Beijing, China2
Capital Medical University2
Shenzhen Raysight Intelligent Medical Technology Co., Ltd.2
Chinese Academy of Medical Sciences, Fuwai Hospital1
DK Medical Technology (Suzhou) Co., Ltd.1
Duk-Woo Park, MD1
Fudan University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Stenosis36
Coronary Artery Disease21
Coronary Restenosis8
Myocardial Ischemia7
Coronary Disease4
Vascular Diseases4
Cardiovascular Diseases3
Disease Progression3
Inflammation3
Stroke2

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.